KMYY(SH:600518)2015-10-28 16:00Financial Performance - Net profit attributable to shareholders increased by 40.67% to CNY 2,107,492,834.23 for the first nine months of the year[6]. - Operating revenue for the first nine months rose by 16.22% to CNY 13,455,418,683.41 compared to the same period last year[6]. - Basic earnings per share increased by 40.47% to CNY 0.479 per share[6]. - The weighted average return on equity increased by 0.30 percentage points to 12.02%[6]. - Total revenue for Q3 2015 reached ¥4,390,281,699.41, an increase of 15.1% compared to ¥3,815,373,571.07 in Q3 2014[35]. - Year-to-date revenue for 2015 was ¥13,455,418,683.41, up 16.2% from ¥11,577,296,262.73 in the same period last year[35]. - The company's operating revenue for Q3 2015 was approximately ¥3.80 billion, an increase of 10.8% compared to ¥3.43 billion in Q3 2014[39]. - The net profit attributable to shareholders for Q3 2015 was ¥653.14 million, representing a 32.3% increase from ¥494.04 million in Q3 2014[39]. - Total comprehensive income for Q3 2015 reached ¥630,696,215.46, compared to ¥502,598,876.85 in Q3 2014, reflecting an increase of approximately 25.5% year-over-year[40]. Assets and Liabilities - Total assets increased by 18.44% to CNY 33,020,316,900.43 compared to the end of the previous year[6]. - Total assets as of September 30, 2015, amounted to ¥31,167,678,164.08, compared to ¥26,193,901,361.34 at the beginning of the year, representing an increase of 19.0%[33]. - Current liabilities increased to ¥9.59 billion from ¥8.25 billion, which is an increase of about 16.2%[28]. - The company's long-term debt, including bonds payable, rose to ¥4.88 billion from ¥2.50 billion, showing a significant increase of approximately 95.5%[28]. - Total liabilities reached ¥13,214,443,883.37, up from ¥9,618,623,171.50 at the start of the year, indicating a 37.0% increase[33]. Cash Flow - The net cash flow from operating activities decreased by 63.54% to CNY 613,155,923.86 year-to-date[6]. - The net cash flow from operating activities decreased by 1,068,690,692.86, a decline of 63.54% compared to the previous period[16]. - The net cash flow from investing activities improved by 600,350,264.31, reflecting a 56.51% increase[16]. - Cash inflow from operating activities for the first nine months of 2015 was ¥14,816,923,673.98, an increase of 7.3% from ¥13,808,565,968.28 in the same period of 2014[42]. - Cash flow from financing activities generated a net inflow of ¥2,343,746,475.11 in the first nine months of 2015, compared to a net outflow of -¥1,880,896,802.20 in the previous year[43]. Shareholder Information - The total number of shareholders reached 246,940 at the end of the reporting period[9]. - The largest shareholder, Kangmei Industrial Co., Ltd., holds 30.42% of the shares, with 1,337,748,548 shares pledged[9]. - The total number of preferred shareholders is 9, with the top ten preferred shareholders holding a total of 36,602,200 shares[13]. - The largest preferred shareholder, 博时基金－工商银行－博时－工行－灵活配置 5号特定多个客户资产管理计划, holds 9,000,000 shares[14]. - The report indicates that 康美实业有限公司's controlling shareholder has connections with other major shareholders, suggesting potential influence in shareholder decisions[12]. Operational Metrics - The total number of unrestricted circulating shares held by the top ten shareholders is 1,337,748,548 shares, with 康美实业有限公司 holding the largest share at 1,337,748,548 shares[11]. - Prepayments increased by 204,809,054.35, representing a growth of 34.29% compared to the beginning of the period[15]. - Interest receivables surged by 20,485,932.87, marking a significant increase of 416.58%[15]. - Other receivables rose by 25,567,600.72, reflecting a 48.05% increase[15]. - Goodwill increased by 81,145,101.75, which is a 36.29% rise due to new acquisitions during the reporting period[15]. Future Plans and Governance - The company plans to enhance its overall strength and profitability through talent acquisition and governance improvements[24]. - The issuance of preferred shares is expected to cover its dividend costs while supporting the construction of projects in the traditional Chinese medicine sector[24]. - The company aims to improve sales revenue and future earnings through effective use of raised funds[24]. - The company has committed to not distributing profits to shareholders in the event of financial difficulties, ensuring funds are directed towards debt repayment and project investments[24].